Compare STE & XPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STE | XPO |
|---|---|---|
| Founded | 1985 | 2000 |
| Country | United States | United States |
| Employees | 3700 | N/A |
| Industry | Industrial Specialties | Transportation Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.1B | 21.3B |
| IPO Year | 2018 | 2002 |
| Metric | STE | XPO |
|---|---|---|
| Price | $222.43 | $211.78 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 18 |
| Target Price | ★ $275.20 | $175.82 |
| AVG Volume (30 Days) | 662.4K | ★ 1.2M |
| Earning Date | 05-13-2026 | 04-30-2026 |
| Dividend Yield | ★ 1.13% | N/A |
| EPS Growth | ★ 62.73 | N/A |
| EPS | ★ 5.69 | 2.64 |
| Revenue | $5,459,515,000.00 | ★ $7,744,000,000.00 |
| Revenue This Year | $9.88 | $5.50 |
| Revenue Next Year | $6.32 | $6.53 |
| P/E Ratio | ★ $39.27 | $80.43 |
| Revenue Growth | ★ 6.24 | 0.34 |
| 52 Week Low | $209.98 | $91.66 |
| 52 Week High | $269.44 | $220.50 |
| Indicator | STE | XPO |
|---|---|---|
| Relative Strength Index (RSI) | 44.30 | 64.85 |
| Support Level | $219.58 | $123.93 |
| Resistance Level | $226.33 | $220.50 |
| Average True Range (ATR) | 4.35 | 7.36 |
| MACD | 1.49 | 2.32 |
| Stochastic Oscillator | 60.28 | 88.01 |
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.
Following the spinoff of its contract logistics division (GXO) in 2021 and freight brokerage operations (RXO) in 2022, XPO is moving closer to becoming a pure-play asset-based less-than-truckload carrier. We estimate LTL shipping makes up 60% of total revenue, with XPO's European truckload and LTL operations making up 40%. However, XPO's LTL segment EBITDA mix is much higher than 60%. We believe XPO intends to divest its European trucking division once it finds the right buyer.